Redmile Group as of Dec. 31, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 71 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 17.2 | $758M | 13M | 58.51 | |
| Amicus Therapeutics (FOLD) | 6.0 | $262M | 23M | 11.55 | |
| Science 37 Holdings | 5.6 | $247M | 20M | 12.47 | |
| Argenx Se Sponsored Adr (ARGX) | 4.2 | $183M | 522k | 350.19 | |
| Livanova SHS (LIVN) | 4.1 | $180M | 2.1M | 87.43 | |
| Kymera Therapeutics (KYMR) | 3.7 | $164M | 2.6M | 63.49 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.4 | $151M | 7.5M | 20.20 | |
| Beam Therapeutics (BEAM) | 3.4 | $150M | 1.9M | 79.69 | |
| Krystal Biotech (KRYS) | 2.9 | $127M | 1.8M | 69.95 | |
| The Beauty Health Company Com Cl A (SKIN) | 2.8 | $123M | 5.1M | 24.16 | |
| Replimune Group (REPL) | 2.4 | $105M | 3.9M | 27.10 | |
| Atara Biotherapeutics | 2.3 | $102M | 6.4M | 15.76 | |
| Igm Biosciences (IGMS) | 2.2 | $98M | 3.3M | 29.33 | |
| Nurix Therapeutics (NRIX) | 1.9 | $86M | 3.0M | 28.95 | |
| Celldex Therapeutics Com New (CLDX) | 1.9 | $84M | 2.2M | 38.64 | |
| Absci Corp (ABSI) | 1.5 | $66M | 8.0M | 8.20 | |
| Verve Therapeutics (VERV) | 1.4 | $63M | 1.7M | 36.87 | |
| Regenxbio Inc equity us cm (RGNX) | 1.4 | $62M | 1.9M | 32.70 | |
| ImmunoGen | 1.4 | $61M | 8.3M | 7.42 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $61M | 2.4M | 24.84 | |
| Repare Therapeutics Ord (RPTX) | 1.3 | $59M | 2.8M | 21.09 | |
| Invitae (NVTAQ) | 1.3 | $58M | 3.8M | 15.27 | |
| Seagen | 1.3 | $58M | 372k | 154.60 | |
| Stoke Therapeutics (STOK) | 1.2 | $54M | 2.2M | 23.99 | |
| UnitedHealth (UNH) | 1.2 | $53M | 105k | 502.14 | |
| ICU Medical, Incorporated (ICUI) | 1.2 | $52M | 220k | 237.34 | |
| Anthem (ELV) | 1.2 | $51M | 110k | 463.54 | |
| Somalogic Class A Com | 1.1 | $48M | 4.1M | 11.64 | |
| Shattuck Labs (STTK) | 1.1 | $48M | 5.6M | 8.51 | |
| Augmedix (AUGX) | 1.0 | $45M | 14M | 3.15 | |
| Gritstone Oncology Ord (GRTSQ) | 1.0 | $44M | 3.4M | 12.86 | |
| Pliant Therapeutics (PLRX) | 0.9 | $42M | 3.1M | 13.50 | |
| Oak Street Health | 0.9 | $40M | 1.2M | 33.14 | |
| Prothena Corp SHS (PRTA) | 0.9 | $38M | 766k | 49.40 | |
| Annexon (ANNX) | 0.8 | $37M | 3.2M | 11.49 | |
| Akero Therapeutics (AKRO) | 0.8 | $34M | 1.6M | 21.15 | |
| Entrada Therapeutics (TRDA) | 0.8 | $34M | 2.0M | 17.12 | |
| Nuvation Bio Com Cl A (NUVB) | 0.7 | $31M | 3.7M | 8.50 | |
| Centene Corporation (CNC) | 0.7 | $30M | 361k | 82.40 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.6 | $26M | 1.2M | 22.45 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.6 | $26M | 662k | 39.56 | |
| Iveric Bio | 0.6 | $25M | 1.5M | 16.72 | |
| Oncology Institu (TOI) | 0.6 | $24M | 2.5M | 9.75 | |
| Immatics SHS (IMTX) | 0.5 | $24M | 1.8M | 13.44 | |
| Nevro (NVRO) | 0.5 | $22M | 270k | 81.07 | |
| Allakos | 0.5 | $20M | 2.1M | 9.79 | |
| Bioventus Com Cl A (BVS) | 0.4 | $19M | 1.3M | 14.49 | |
| Neoleukin Therapeutics | 0.4 | $17M | 3.5M | 4.82 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $17M | 782k | 21.49 | |
| Zogenix Com New | 0.4 | $16M | 998k | 16.25 | |
| Medavail Holdings Ord | 0.4 | $16M | 11M | 1.40 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.4 | $16M | 2.8M | 5.50 | |
| Alpha Teknova (TKNO) | 0.3 | $15M | 725k | 20.48 | |
| Zymeworks | 0.3 | $14M | 874k | 16.39 | |
| Adagio Therapeutics (IVVD) | 0.3 | $14M | 1.9M | 7.26 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.3 | $13M | 98k | 127.40 | |
| Allovir (ALVR) | 0.2 | $11M | 823k | 12.94 | |
| Stereotaxis Com New (STXS) | 0.2 | $11M | 1.7M | 6.20 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $11M | 2.1M | 5.01 | |
| Ngm Biopharmaceuticals | 0.2 | $10M | 583k | 17.71 | |
| Avita Therapeutics (RCEL) | 0.2 | $8.1M | 672k | 11.98 | |
| Deciphera Pharmaceuticals | 0.1 | $6.5M | 665k | 9.77 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $6.3M | 1.3M | 4.66 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $5.7M | 668k | 8.51 | |
| Hookipa Pharma Inc equity | 0.1 | $5.6M | 2.4M | 2.33 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $3.1M | 1.0M | 2.93 | |
| Cytosorbents Corp Com New (CTSO) | 0.1 | $3.0M | 717k | 4.19 | |
| Sonendo (SONX) | 0.1 | $2.9M | 498k | 5.76 | |
| Cabaletta Bio (CABA) | 0.1 | $2.6M | 696k | 3.79 | |
| Atreca Cl A Com (BCEL) | 0.1 | $2.4M | 800k | 3.03 | |
| Epizyme | 0.0 | $1.1M | 455k | 2.50 |